Text Size
S
M
L
Listen
Santen Global
menu
Patients
Healthcare Professionals
Careers
Investors
Listen
Tap on the left to use.
Who We Are
Message
Message from the CEO
Santen’s Corporate Philosophy Framework
Santen’s Corporate Philosophy Framework
History
History of Santen
Corporate Executives
Corporate Executives
Corporate Governance
Corporate Governance
Digital Transformation
Digital Transformation
Policies
Policies and Statements
Company Infomation
Overview / Map
Global Operation
What We Do
MTP
Medium-term Management Plan
Efforts to Enhance Patients' Satisfaction
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Research & Development
Research & Development
The Ophthalmic Development Process
Clinical Trial Information
Partnering
Santen's Partnership
Our Partners
Partnering Contact
Production
Production
Safety and Quality Assurance
The Ophthalmic Production Process
Our Stories
Sustainability
Sustainability
Our Sustainability Commitment
Sustainability at Santen
Social
Access to Healthcare
Research & Development in Ophthalmology
Product Quality & Safety
Supply Chain
Human Rights
Talent
Governance
Corporate Governance
Compliance
Ethical Marketing
Risk Management
Information Security
Environment
Environmental initiatives
Measures against Climate Change
Environmental Load Reduction
Biodiversity
Disclosures Based on the TCFD Recommendations
Inclusion
Inclusive Society Santen Promotes
Inclusion Starting from Blind Football
Together with Society
With Employees
Related Information
Participating in the UN Global Compact
Social Contribution Activities
Stakeholder Engagement
Environment Data (up-to-date)
Social Data (up-to-date)
Governance Data (up-to-date)
GRI Standards Content Index
Sustainability Library
External Assessment
News
News
Show All
Press Release
IR News
Information
HOME
News
2018
2018 News
Press Release
IR News
Information
Press Release
07.10.2018
Santen Receives Marketing Authorisation from the European Commission for DE-076C (Verkazia) as an Orphan Medicinal Product
02.23.2018
Santen to Conduct a Public Awareness Campaign for Glaucoma During World Glaucoma Week March 11 - 17
Press Release
IR News
11.27.2018
Santen and Ube Industries Announce Launch of Glaucoma and Ocular Hypertension Treatment EYBELIS Ophthalmic Solution 0.002% in Japan
11.22.2018
Corporate Governance Report
11.07.2018
Santen Reports the 2nd Quarter Fiscal 2018 Consolidated Performance
09.25.2018
Santen Donates to the 2018 Hokkaido Eastern Iburi Earthquake Relief Efforts in Japan
09.25.2018
Santen Announces Drug Discovery and Development Agreement with PeptiDream
IR News
Information
12.25.2018
Corporate Social Responsibility (CSR) page on our website has been updated
10.23.2018
Corporate Social Responsibility (CSR) page on our website has been updated
06.28.2018
Corporate Social Responsibility (CSR) page on our website has been updated
03.29.2018
CSR page on our website has been updated
02.20.2018
Santen Awarded for Corporate Governance
Information
News Archive
